abstract |
The use of one of the following compounds for the manufacture of a medicament for the treatment of atherosclerosis and peripheral vascular diseases: 2- (acetyloxy) benzoic acid (X) ester 3- (nitrooxymethyl) phenyl ester of (4-nitrooxy) butyl ester 2- (acetyloxy) benzoic acid 2- (acetyloxy) benzoic acid 2- (acetyloxy) benzoic acid 2- (nitroxymethyl) phenyl ester 2- (acetyloxy) benzoic acid (XIII) 2-methoxy ester 2- (acetyloxy) benzoic acid (XIV) 6- (nitrooxymethyl) -2-methyl pyrididyl hydrochloride ester 4 - [(1E) -3- [4-nitrooxy butoxy] -3-oxo-1-propenyl] phenyl 2- (acetyloxy) benzoic acid (XV) 3- (nitrooxymethyl) phenyl ester of 2-hydroxybenzoic acid (XVI) 4- (nitrooxymethyl) phenyl ester of 2- (hydroxy) benzoic acid (XVII) 4- (nitrooxy) butyl ester of 2- (hydroxymethyl) phenyl ester 2- (hydroxymethyl) phenyl acid acid 2- (hydroxybenzoic acid (XIX) ester 2-methoxy-4 - [(1E) -3- (4-nitrooxybutyl] -3-oxo -1-propenyl] fen Lico (XX) N-acetylcysteine, 4-nitrooxybutyl ester, 2-acetyloxybenzoate (XXI) 2-hydroxybenzoic acid, 6- (nitrooxymethyl) -2-methylpyridinyl hydrochloride ester (XXII) 2-hydroxybenzoic acid, 5-hydroxybenzoic acid ester - (nitrooxymethyl) -2-methyl pyridinyl (XXIII) 2-hydroxybenzoic acid, 3- (nitroxymethyl) -2-methylpyridinyl hydrochloride (XXIV) 2- (acetyloxy) benzoic acid, 5- (nitrooxymethyl) -2 hydrochloride ester -methylpyridinyl (XXV) 2-hydroxybenzoic acid, 6- (nitroxymethyl) -2-methyl pyridinyl hydrochloride ester (XXVI) 2-hydroxybenzoic acid, 5- (nitroxymethyl) -2-methyl pyridinyl hydrochloride ester (XXVII) 2-hydroxybenzoic acid, 3- (nitroxymethyl) -2-methyl pyridinyl hydrochloride ester (XXVIII) 2-acetyloxy) benzoic acid, 5- (nitroxymethyl) -2-pyridinyl hydrochloride ester (XXIX) 2- (acetyloxy) benzoic acid , 3- (nitrooxymethyl) -2-methyl-pyrimidinyl (XXX) hydrochloride ester 2- (acetyloxy) benzoic acid, 3- (nitroox hydrochloride ester imetyl) -2-methyl-pyrimidinyl (XXXI) |